218 related articles for article (PubMed ID: 31564074)
21. Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells.
Jung Y; Jang YJ; Kang MH; Park YS; Oh SJ; Lee DC; Xie Z; Yoo HS; Park KC; Yeom YI
Mol Cells; 2013 Apr; 35(4):335-41. PubMed ID: 23515579
[TBL] [Abstract][Full Text] [Related]
22. Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.
Dong T; Kang X; Liu Z; Zhao S; Ma W; Xuan Q; Liu H; Wang Z; Zhang Q
Tumour Biol; 2016 Jun; 37(6):8159-68. PubMed ID: 26715276
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
[TBL] [Abstract][Full Text] [Related]
24. SAM68 promotes tumorigenesis in lung adenocarcinoma by regulating metabolic conversion via PKM alternative splicing.
Zhu S; Chen W; Wang J; Qi L; Pan H; Feng Z; Tian D
Theranostics; 2021; 11(7):3359-3375. PubMed ID: 33537092
[No Abstract] [Full Text] [Related]
25. Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms.
Taniguchi K; Ito Y; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Sugiyama T; Futamura M; Otsuki Y; Yoshida K; Uchiyama K; Akao Y
Sci Rep; 2015 Feb; 5():8647. PubMed ID: 25721733
[TBL] [Abstract][Full Text] [Related]
26. The ubiquitin ligase KBTBD8 regulates PKM1 levels via Erk1/2 and Aurora A to ensure oocyte quality.
Li YR; Peng RR; Gao WY; Liu P; Chen LJ; Zhang XL; Zhang NN; Wang Y; Du L; Zhu FY; Wang LL; Li CR; Zeng WT; Li JM; Hu F; Zhang D; Yang ZX
Aging (Albany NY); 2019 Feb; 11(4):1110-1128. PubMed ID: 30786262
[TBL] [Abstract][Full Text] [Related]
27. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism.
Wang HJ; Hsieh YJ; Cheng WC; Lin CP; Lin YS; Yang SF; Chen CC; Izumiya Y; Yu JS; Kung HJ; Wang WC
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):279-84. PubMed ID: 24344305
[TBL] [Abstract][Full Text] [Related]
28. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
[TBL] [Abstract][Full Text] [Related]
29. Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer.
Huang L; Yu Z; Zhang Z; Ma W; Song S; Huang G
Sci Rep; 2016 Mar; 6():22449. PubMed ID: 26926077
[TBL] [Abstract][Full Text] [Related]
30. NF-κB/RelA-PKM2 mediates inhibition of glycolysis by fenofibrate in glioblastoma cells.
Han D; Wei W; Chen X; Zhang Y; Wang Y; Zhang J; Wang X; Yu T; Hu Q; Liu N; You Y
Oncotarget; 2015 Sep; 6(28):26119-28. PubMed ID: 26172294
[TBL] [Abstract][Full Text] [Related]
31. PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation.
Zhang L; Bailleul J; Yazal T; Dong K; Sung D; Dao A; Gosa L; Nathanson D; Bhat K; Duhachek-Muggy S; Alli C; Dratver MB; Pajonk F; Vlashi E
Breast Cancer Res Treat; 2019 Nov; 178(1):75-86. PubMed ID: 31372790
[TBL] [Abstract][Full Text] [Related]
32. Muscle-specific pyruvate kinase isoforms, PKM1 and PKM2, regulate mammalian SWI/SNF proteins and histone 3 phosphorylation during myoblast differentiation.
Olea-Flores M; Sharma T; Verdejo-Torres O; DiBartolomeo I; Thompson PR; Padilla-Benavides T; Imbalzano AN
FASEB J; 2024 Jun; 38(11):e23702. PubMed ID: 38837439
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of SASS6 reduces growth of MDA‑MB‑231 triple‑negative breast cancer cells through arrest of the cell cycle at the G2/M phase.
Du L; Jing J; Wang Y; Xu X; Sun T; Shi Y; Wang W; Tian B; Han C; Zhao X; Chang H
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907854
[TBL] [Abstract][Full Text] [Related]
34. Silencing of Pyruvate Kinase M2
Huang S; Zhu W; Zhang F; Chen G; Kou X; Yang X; Ouyang G; Shen J
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56972-56987. PubMed ID: 34797638
[TBL] [Abstract][Full Text] [Related]
35. PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis.
Liu F; Ma F; Wang Y; Hao L; Zeng H; Jia C; Wang Y; Liu P; Ong IM; Li B; Chen G; Jiang J; Gong S; Li L; Xu W
Nat Cell Biol; 2017 Nov; 19(11):1358-1370. PubMed ID: 29058718
[TBL] [Abstract][Full Text] [Related]
36. miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect.
Sun Y; Zhao X; Zhou Y; Hu Y
Oncol Rep; 2012 Oct; 28(4):1346-52. PubMed ID: 22895557
[TBL] [Abstract][Full Text] [Related]
37. MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer.
Tang R; Yang C; Ma X; Wang Y; Luo D; Huang C; Xu Z; Liu P; Yang L
Oncotarget; 2016 Feb; 7(5):5972-84. PubMed ID: 26745603
[TBL] [Abstract][Full Text] [Related]
38. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
39. Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
Lee JS; Oh Y; Lee JS; Park JH; Shin JK; Han JH; Kim HS; Yoon S
In Vivo; 2022; 36(5):2105-2115. PubMed ID: 36099094
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
